Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cognitive dysfunction in multiple sclerosis: a review of recent developments.

Julie A Bobholz1, Stephen M Rao

  • 1Department of Neurology, Medical College of Wisconsin, 9200 West Wisconsin Avenue, Milwaukee, WI 53226, USA. jbobholz@mcw.edu

Current Opinion in Neurology
|July 15, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Clinical Manifestations.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

Biomarkers.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

Developing Topics.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2025
Same author

The Functional Connectome Mediates Associations Between Fitness and Cognition Across the Adult Lifespan.

Human brain mapping·2025
Same author

Evaluation of two clinical Centiloid analysis products for <sup>18</sup>F-florbetapir PET in cognitively unimpaired elders.

Alzheimer's & dementia (Amsterdam, Netherlands)·2025
Same author

Protocol of a randomized, single-blind, controlled trial of an 18-month, home-based, high-intensity, exercise intervention in older, cognitively unimpaired <i>APOE</i> ε4 carriers.

Frontiers in aging neuroscience·2025
Same journal

Multimodal mapping of balance dysfunction in Parkinson's disease: a consensus roadmap for research and intervention.

Current opinion in neurology·2026
Same journal

Tourette syndrome: brain neurophysiology, circuit dysfunction, and neuromodulation across invasive and noninvasive approaches.

Current opinion in neurology·2026
Same journal

Dystonia: from phenotypes to genetics and therapeutic advances.

Current opinion in neurology·2026
Same journal

What can we learn from eye movements in movement disorders and Parkinson's disease?

Current opinion in neurology·2026
Same journal

Functional movement disorders: diagnosis, pathophysiology, and treatment.

Current opinion in neurology·2026
Same journal

Galectins in the brain: advances in neuroinflammation, neuroprotection and therapeutic opportunities: Erratum.

Current opinion in neurology·2026
See all related articles

Cognitive dysfunction impacts nearly half of multiple sclerosis patients, affecting daily living. Disease-modifying therapies may slow cognitive decline and improve daily activities by reducing MRI-visible disease activity.

Area of Science:

  • Neuroscience
  • Neurology
  • Clinical Medicine

Background:

  • Cognitive dysfunction affects nearly half of multiple sclerosis (MS) patients.
  • This cognitive impairment is linked to a significant decline in daily living activities.
  • Understanding and managing cognitive issues in MS is crucial for patient quality of life.

Purpose of the Study:

  • To review recent literature on cognitive dysfunction in multiple sclerosis (MS).
  • To explore the relationship between cognitive deficits and daily functioning in MS.
  • To examine potential treatments and neurobiological correlates of cognitive impairment in MS.

Main Methods:

  • Literature review of recent studies on MS cognitive dysfunction.
  • Analysis of studies examining cognitive processes, natural history, and daily living skills.

Related Experiment Videos

  • Inclusion of research focusing on neuroimaging correlates and treatment investigations.

    • Main Results:

    • Increased understanding of specific cognitive processes affected in MS and its natural history.
    • Strong association between cognitive deficits and decline in daily living skills, including driving.
    • Neuroimaging techniques reveal correlations between disease activity/lesion burden and cognitive deficits.
    • Emerging research on potential treatments for cognitive dysfunction in MS.

    Conclusions:

    • Disease-modifying medications show potential in impacting MRI-visible disease activity.
    • These therapies may slow the progression of cognitive decline over time.
    • Treatment may lead to improved activities of daily living for patients with multiple sclerosis.